Filgrastim biosimilar (Eurofarma)

非格司亭生物类似药（Eurofarma）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Eurofarma)

Drug Alias NameFilgrastimum (Eurofarma)非格司亭生物仿制药（Eurofarma）Recombinant human granulocyte macrophage colony stimulating factor (Eurofarma)重组人粒细胞刺激因子（Eurofarma）Granulen

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryBrazil

Original Approved Date2012/01/01

Country/TerritoryBrazil

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesEurofarma

China Registration ClassN/A

Develop Information

Active CompaniesEurofarma

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02